Dr. Smith-Whitley is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
3401 Civic Center Blvd
# Children
Philadelphia, PA 19104Phone+1 215-590-3535Fax+1 215-590-3992
Education & Training
- Children's Hospital of PhiladelphiaFellowship, Pediatric Hematology/Oncology, 1992 - 1995
- Children's National HospitalResidency, Pediatrics, 1989 - 1992
- George Washington University School of Medicine and Health SciencesClass of 1989
Certifications & Licensure
- PA State Medical License 1992 - 2024
- American Board of Pediatrics Pediatric Hematology-Oncology
Awards, Honors, & Recognition
- Super Doctor SuperDoctors.com
Clinical Trials
- Priapism in Boys and Men With Sickle Cell Disease - Demographics, Characteristics and Prevalence Start of enrollment: 2005 Aug 01
- Effectiveness of Arginine as a Treatment for Sickle Cell Anemia Start of enrollment: 2004 Jun 01
- A Study of Prasugrel in Pediatric Participants With Sickle Cell Disease (SCD) Start of enrollment: 2013 Apr 01
- Join now to see all
Publications & Presentations
PubMed
- The pervasive influence of systems of power on transition readiness for adult care in sickle cell disease: A qualitative study.Kemar V Prussien, Haley L Faust, Lori E Crosby, Kim Smith-Whitley, Lamia P Barakat
Pediatric Blood & Cancer. 2024-09-01 - 1 citationsAssessing multilevel barriers to hydroxyurea adherence in youth with sickle cell disease using pharmacy-based refill records.Arlene Smaldone, Deepa Manwani, Banu Aygun, Abena Appiah-Kubi, Kim Smith-Whitley
Pediatric Blood & Cancer. 2024-09-01 - 1 citationsIdentification of genetic variants associated with clinical features of sickle cell disease.Katharine Tsukahara, Xiao Chang, Frank Mentch, Kim Smith-Whitley, Anita Bhandari
Scientific Reports. 2024-08-29
Abstracts/Posters
- Clinical Practice Patterns for Hydroxyurea Initiation in Young Children with Sickle Cell DiseaseKim Smith-Whitley, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019
- Crizanlizumab 5.0 Mg/Kg Exhibits a Favorable Safety Profile in Patients with Sickle Cell Disease: Pooled Data from Two Phase II StudiesKim Smith-Whitley, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/7/2019
- 2'-O-Methoxyethyl Splice-Switching Oligos to Reverse Splicing from IVS2-745 _-Thalassemia Patient Cells: A Foundation for Potential TherapiesKim Smith-Whitley, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/8/2019
- Join now to see all
Authored Content
- For People with Sickle Cell Disease, Add Check-Ins to CheckupsOctober 2021
Press Mentions
- GBT and Sickle Cell Disease Association of America to Host 11th Annual Sickle Cell Disease Therapeutics ConferenceSeptember 8th, 2022
- GBT Announces Five Data Presentations on Sickle Cell Disease at Upcoming EHA2022 CongressMay 12th, 2022
- Global Blood Therapeutics (GBT) Q1 2022 Earnings Call TranscriptMay 4th, 2022
- Join now to see all
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: